Abstract
The Icelandic Medicines Registry (IMR) is a prescription database containing all prescriptions filled in pharmacies for individuals living in Iceland who are covered by the Icelandic social insurance system. The IMR was set up for the Directorate of Health to evaluate national use of prescription medicines, to monitor drug prescribing, and to promote rational use of drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aradottir AB, Gudmundsson LS, Jonsdottir LS et al (2015) Icelandic Medicines Registry—role and operation 2005–2014. Directorate of Health, Reykjavik, Iceland
Furu K, Karlstad O, Zoega H et al (2017) Utilization of stimulants and atomoxetine for attention-deficit/hyperactivity disorder among 5.4 million children using population-based longitudinal data. Basic Clin Pharmacol Toxicol 120(4):373–379. https://doi.org/10.1111/bcpt.12724
Furu K, Kieler H, Haglund B et al (2015) Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 350:h1798. https://doi.org/10.1136/bmj.h1798
Furu K, Wettermark B, Andersen M et al (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106(2):86–94. https://doi.org/10.1111/j.1742-7843.2009.00494.x
Geirs DP, Pottegard A, Halldorsson M et al (2014) A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003–2012. Basic Clin Pharmacol Toxicol 115(5):417–422. https://doi.org/10.1111/bcpt.12243
Gudbjornsson B, Thorsteinsson SB, Sigvaldason H et al (2010) Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. Eur J Clin Pharmacol 66(6):619–625. https://doi.org/10.1007/s00228-010-0789-2
Halfdanarson O, Zoega H, Aagaard L et al (2017) International trends in antipsychotic use: a study in 16 countries, 2005–2014. Eur Neuropsychopharmacol 27(10):1064–1076. https://doi.org/10.1016/j.euroneuro.2017.07.001
Halfdanarson OO, Fall K, Ogmundsdottir MH et al (2019a) Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: an Icelandic population-based case-control study. Pharmacoepidemiol Drug Saf 28(4):471–478. https://doi.org/10.1002/pds.4702
Halfdanarson OO, Pottegard A, Bjornsson ES et al (2018) Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol 11:1756284818777943. https://doi.org/10.1177/1756284818777943
Halfdanarson OO, Pottegard A, Lund SH et al (2019b) Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancer. Basic Clin Pharmacol Toxicol. https://doi.org/10.1111/bcpt.13379
Huybrechts KF, Broms G, Christensen LB et al (2018) Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium. JAMA Psychiatry 75(2):167–175. https://doi.org/10.1001/jamapsychiatry.2017.3644
Johannsson M, Haraldsdottir S (2012) Research in pharmacoepidemiology in Iceland. Laeknabladid 98(4):217–222
Karlstad O, Zoega H, Furu K et al (2016) Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol 72(12):1507–1514. https://doi.org/10.1007/s00228-016-2125-y
Kieler H, Artama M, Engeland A et al (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 344:d8012. https://doi.org/10.1136/bmj.d8012
Kieler H, Malm H, Artama M et al (2015) Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG 122(12):1618–1624. https://doi.org/10.1111/1471-0528.13164
Linnet K, Sigurdsson JA, Tomasdottir MO et al (2019) Association between prescription of hypnotics/anxiolytics and mortality in multimorbid and non-multimorbid patients: a longitudinal cohort study in primary care. BMJ Open 9(12):e033545. https://doi.org/10.1136/bmjopen-2019-033545
Stephansson O, Kieler H, Haglund B et al (2013) Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 309(1):48–54. https://doi.org/10.1001/jama.2012.153812
Thorsdottir G, Benedikz E, Thorgeirsdottir SA et al (2017) Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures? Laeknabladid 103(5):231–235. https://doi.org/10.17992/lbl.2017.05.136
Wettermark B, Zoega H, Furu K et al (2013) The Nordic prescription databases as a resource for pharmacoepidemiological research–a literature review. Pharmacoepidemiol Drug Saf 22(7):691–699. https://doi.org/10.1002/pds.3457
Zoega H, Baldursson G, Hrafnkelsson B et al (2009) Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol 19(6):757–764. https://doi.org/10.1089/cap.2009.0003
Zoega H, Furu K, Halldorsson M et al (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123(5):360–367. https://doi.org/10.1111/j.1600-0447.2010.01607.x
Zoega H, Kieler H, Norgaard M et al (2015) Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden. PLoS One 10(12):e0144474. https://doi.org/10.1371/journal.pone.0144474
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gudmundsson, L.S., Einarsson, O.B., Johannsson, M. (2021). Icelandic Medicines Registry (IMR). In: Sturkenboom, M., Schink, T. (eds) Databases for Pharmacoepidemiological Research. Springer Series on Epidemiology and Public Health. Springer, Cham. https://doi.org/10.1007/978-3-030-51455-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-51455-6_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-51454-9
Online ISBN: 978-3-030-51455-6
eBook Packages: MedicineMedicine (R0)